A cost and outcome model of fertility treatment in a managed care environment

Fertility and Sterility

Volumn 66, Issue 6, 1996, Pages 896-903

  Rabin, D S ^a   Qadeer, U ^a   Steir, V E ^a  

^a ADVOCATE LUTHERAN GENERAL HOSPITAL   (United States)

Author keywords

Cost; fertility; IVF ET; managed care; outcome

Indexed keywords

ADULT; ARTICLE; CLINICAL PRACTICE; CLINICAL PROTOCOL; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILITY; FERTILIZATION IN VITRO; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL FEE; OVULATION INDUCTION; PRACTICE GUIDELINE; PREGNANCY RATE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0030463553     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(16)58681-6     Document Type: Article

References (41)

1. J.K. Iglehart The American health care system: managed care N Engl J Med 327 1992 742 747
2. R.H. Miller H.S. Luft Managed care plan performance since 1980: a literature analysis JAMA 271 1994 1512 1519
3. D. Ermann J. Richmond Managed care arrangements: barriers to cost savings potential Med Care Rev 51 1994 125 148
4. W.G. Manning J.P. Newhouse N. Duan E.B. Keeler A. Leibowitz M.S. Marquis Health insurance and the demand for medical care: evidence from a randomized experiment Am Econ Rev 77 1987 251 277
5. Understanding and using capitation Economic Impact, Department of Health Economic Analysis February 1995 ACOG Washington, DC
6. J.A. Collins Reproductive technology—the price of progress N Engl J Med 331 1994 270 271
7. G.S. Cooper An analysis of the costs of infertility treatment Am J Public Health 76 1986 1018 1019
8. P.J. Neumann S.D. Gharib M.C. Weinstein The cost of a successful delivery with in vitro fertilization N Engl J Med 331 1994 239 243
9. R. Goeree R. Labelle J.F. Jarrell Cost-effectiveness of an in vitro fertilization program and the costs of associated hospitalizations and other infertility treatments New reproductive technologies and the health care system: the case for evidence-based medicine 1993 Ministry of Supply and Services Ottawa, Ontario, Canada 569 599
10. B.J. Van Voorhis C.H. Syrop B.D. Allen A.E.T. Sparks D.W. Stovall The efficacy and cost effectiveness of embryo cryopreservation compared with other assisted reproductive techniques Fertil Steril 64 1995 647 650
11. P.H. Wessels H.S. Cronje A.P. Oosthuizen M.D. Trumpelmann S. Grobler D.K. Hamlett Cost-effectiveness of gamete intrafallopian transfer in comparison with induction of ovulation with gonadotropins in the treatment of female infertility: a clinical trial Fertil Steril 57 1992 163 167
12. A.H. DeCherney Infertility: we’re not taking new patients Fertil Steril 64 1995 470 473
13. R. Brealey S. Myers Principles of corporate finance 2nd rev. ed 1984 McGraw-Hill, Inc. New York
14. M.F. Drummond L. Davies Economic analysis alongside clinical trials: revisiting the methodological issues Int J Technol Assess Health Care 7 1991 561 573
15. D.L. Healy A.O. Trounson A.N. Andersen Female infertility: causes and treatment Lancet 343 1994 1539 1544
16. H.W. Jones Jr. J.P. Toner Current concepts: the infertile couple N Engl J Med 329 1994 1710 1715
17. L. Speroff R.H. Glass N.G. Kase Clinical gynecologic endocrinology and infertility 5th ed. 1994 Williams and Wilkins Baltimore
18. Anonymous Services per 1000 non-elderly enrollees for Ob/Gyn CPT codes, two private insurers, 1992 and 1993 Department of Practice Management 1993 ACOG Washington, DC 1995
19. Ventura S.J. Martin J.A. Taffel S.M. Mathews T.J. Clarke S.C. Advance report of final natality statistics, 1992 Monthly Vital Statistics Report, Centers for Disease Control, National Center for Health Statistics 43 5 Suppl 1994 1 26
20. L.S. Wilcox W.D. Mosher Use of infertility services in the United States Obstet Gynecol 82 1993 122 127
21. State of Illinois, House Bill 1470, The Family Building Act. 1991.
22. J.A. Rock ZOLADEX Endometriosis Study Group The revised American Fertility Society classification of endometriosis: reproducibility of scoring Fertil Steril 63 1995 1108 1110
23. Society for Assisted Reproductive Technology, American Society for Reproductive Medicine Assisted reproductive technology in the United States and Canada: 1993 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry Fertil Steril 64 1995 13 21
24. A.F. Guttmacher Factors affecting normal expectancy of conception JAMA 161 1956 855 860
25. J. Menken J. Trussell U. Larsen Age and infertility Science 233 1986 1389 1394
26. J. Vandromme E. Chasse B. Lejeune M. Van Rysselberge A. Delvigne F. Leroy Hydrosalpinges in in-vitro fertilization: an unfavourable prognostic feature Hum Reprod 10 1995 576 579
27. M.P. Milad G.D. Ball L.D. Erickson S.J. Ory R.S. Corfman A successful assisted reproductive technology satellite program Fertil Steril 60 1993 716 719
28. S.K. Agarwal R.P. Buyalos Corpus luteum function and pregnancy rates with CC therapy: comparison of human chorionic gonadotrophin-induced versus spontaneous ovulation Hum Reprod 10 1995 328 331
29. J.G. Franco Jr. R.L.R. Baruffi A.L. Mauri C.G. Petersen M.S. Campos Semi-programmed ovarian stimulation as the first choice in in-vitro fertilization programmes Hum Reprod 10 1995 568 571
30. R.S. Corfman M.P. Milad T.L. Bellavance S.J. Ory L.D. Erickson G.D. Ball A novel ovarian stimulation protocol for use with the assisted reproductive technologies Fertil Steril 60 1993 864 870
31. A. Trounson C. Wood A. Kausche In vitro maturation and the fertilization and developmental competence of oocytes recovered from untreated polycystic ovarian patients Fertil Steril 62 1994 353 362
32. U.M. Fahy D.J. Cahill P.G. Wardle M.G.R. Hull In-vitro fertilization in completely natural cycles Hum Reprod 10 1995 572 575
33. J. Roest A. Verhoeff M. van Lent G.J. Huisman G.H. Zeilmaker Results of decentralized in-vitro fertilization treatment with transport and satellite clinics Hum Reprod 10 1995 563 567
34. D. Feldberg J. Farhi J. Ashkenazi D. Dicker J. Shalev Z. Ben-Rafael Minidose gonadotropin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels Fertil Steril 62 1994 343 346
35. A.F. Haney C.L. Hughes Jr. D.B. Whitesides W.C. Dodson Treatment-independent, treatment associated, and pregnancies after additional therapy in a program of in vitro fertilization and embryo transfer Fertil Steril 47 1987 634 638
36. J.A. Collins W. Wrixon L.B. Janes E.H. Wilson Treatment-independent pregnancy among infertile couples N Engl J Med 309 1983 1201 1206
37. J.A. Collins M. Bustillo R.D. Visscher L.D. Lawrence An estimate of the cost of in vitro fertilization services in the United States in 1995 Fertil Steril 64 1995 538 545
38. U.S. Congress, Office of Technology Infertility: medical and social choices 1988 US Government Printing Office Washington, DC
39. J.P. Kassirer Managed care and the morality of the marketplace N Engl J Med 333 1995 50 52
40. M.L. Rivo H.L. Mays J. Katzoff D.A. Kindig Managed health care: implications for the physician workforce and medical education JAMA 274 1995 712 715
41. D.A. Davis M.A. Thompson A.D. Oxman R.B. Haynes Changing physician performance: a systematic review of the effect of continuing medical education strategies JAMA 274 1995 700 705